Abrupt Intrathecal baclofen withdrawal: Management of potentially life-threatening sequelae

Neuromodulation

Volumn 4, Issue 4, 2001, Pages 142-146

  Coffey, R J ^a   Ridgely, P M ^a  

^a MEDTRONIC INC   (United States)

Author keywords

Baclofen; Gamma amino butyric acid (GABA); Implantable infusion pumps; Spasticity; Spinal cord injury

Indexed keywords

4 AMINOBUTYRIC ACID; BACLOFEN; DIAZEPAM;

AUTONOMIC DYSREFLEXIA; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG IMPLANT; DRUG INFUSION; DRUG WITHDRAWAL; HUMAN; INFUSION PUMP; MALIGNANT HYPERTHERMIA; NEUROLEPTIC MALIGNANT SYNDROME; SPASTICITY; SPINAL CORD INJURY;

EID: 0034748252     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.2001.00142.x     Document Type: Conference Paper

References (37)

1. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy
2. Baclofen in the treatment of cerebral palsy
3. Intrathecal baclofen for spasticity in cerebral palsy
4. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy
5. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study
6. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
7. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: A preliminary report
8. Baclofen intoxication: Report of 4 cases and review of the literature
9. Convulsions after abrupt withdrawal of baclofen
10. Adverse effects secondary to baclofen withdrawal
11. Hallucinations after preoperative baclofen discontinuation in spinal cord injury patients
12. Status epilepticus after baclofen withdrawal
13. Dyskinesia and psychosis in a patient following baclofen withdrawal
14. Prolonged seizure activity after baclofen withdrawal
15. Hallucinations after withdrawal of baclofen
16. Hyperthermia associated with baclofen withdrawal and increased spasticity
17. Rhabdomyolysis and hyperthermia associated with intrathecal baclofen in the absence of pump or catheter defect
18. Withdrawal syndromes. Psychiatric emergencies
19. Prolonged severe withdrawal symptoms after acuteon-chronic baclofen overdose
20. Complications of baclofen withdrawal
21. Death after acute withdrawal of intrathecal baclofen: Case report and literature review
22. Intrathecal baclofen treatment for stiff-man syndrome: Pump failure may be fatal
23. Abrupt withdrawal from intrathecal baclofen. Recognition and management of a potentially life-threatening syndrome
24. Drug therapy. Spasticity (first of two parts)
25. Drug therapy. Spasticity (second of two parts)
26. Intrathecally delivered medications for spasticity and dystonia
27. Intrathecal baclofen down-regulates GABA-B receptors in the rat substantia gelatinosa
28. Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy
29. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury
30. Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure. A case report
31. Hyperthermie grave liée à un severage brutal de baclofène administré de façon continue par voie intrathéscale
32. Dantroene treatment for abrupt intrathecal baclofen withdrawal
33. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter fracture
34. Baclofen withdrawal presenting as multiorgan system failure
35. Development of acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity